Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

Similar articles for PubMed (Select 19874684)

1.

[The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

Lin Q, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):722-5. Chinese. No abstract available.

PMID:
19874684
2.

Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.

Yang JX, Liu BM, Li XG, Yan CH, Xu J, Sun XW, Wang YH, Jiao XJ, Yan L, Dong JP, Hou CS, Abuduheilili X, Li T, Zhuang H.

Antivir Ther. 2010;15(8):1171-8. doi: 10.3851/IMP1677.

PMID:
21149924
3.

[Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy].

Orito E.

Nihon Shokakibyo Gakkai Zasshi. 2007 Oct;104(10):1459-64. Review. Japanese. No abstract available.

PMID:
17917393
4.

Adefovir for lamivudine resistant HBV: more than meets the eye.

Di Marco V, Craxì A.

J Hepatol. 2007 Oct;47(4):618-9; author reply 619-20. Epub 2007 Jul 27. No abstract available.

PMID:
17697727
5.

Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.

Lee JM, Park JY, Kim do Y, Nguyen T, Hong SP, Kim SO, Chon CY, Han KH, Ahn SH.

Antivir Ther. 2010;15(2):235-41. doi: 10.3851/IMP1510.

PMID:
20386079
6.

[Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].

Yang F, Wu XF, Wei N.

Zhonghua Gan Zang Bing Za Zhi. 2010 Jan;18(1):65-6. doi: 10.3760/cma.j.issn.1007-3418.2010.01.017. Chinese. No abstract available.

PMID:
20128975
7.

[Pharmacological agents for the treatment of chronic hepatitis B].

Sánchez-Tapias JM.

Gastroenterol Hepatol. 2008 Mar;31(3):120-8. Review. Spanish. No abstract available.

PMID:
18341843
8.

[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].

Buti M.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:32-8. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100229
9.

Nucleoside analogues for chronic hepatitis B.

Wolters LM, Niesters HG, de Man RA.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1499-506. Review.

PMID:
11742201
10.

Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

Colle I, Adler M, Brenard R, Henrion J, Langlet P, Michielsen P, Orlent H, Reynaert H, Sprengers D, Stärkel P, Van Damme P, Verslype C, Delwaide J; Belgian Association for the Study of the Liver.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):389-420. No abstract available.

PMID:
18330099
11.

[New antiviral agent. Hepatitis B therapy with slight resistance risk].

[No authors listed]

MMW Fortschr Med. 2003 Dec 18;145(51-52):40. German. No abstract available.

PMID:
14974332
12.

Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.

Liu Y, Wang C, Zhong Y, Chen L, Li X, Ji D, Wang H, Xin S, Zoulim F, Xu D.

Antivir Ther. 2010;15(8):1185-90. doi: 10.3851/IMP1679.

PMID:
21149926
13.

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.

Hepatology. 2009 Oct;50(4):1064-71. doi: 10.1002/hep.23145.

PMID:
19637288
14.

Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.

Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.

Antiviral Res. 2007 Aug;75(2):146-51. Epub 2007 Mar 16.

PMID:
17400303
15.

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.

Lampertico P, Colombo M.

Liver Int. 2009 Jan;29 Suppl 1:130-2. doi: 10.1111/j.1478-3231.2008.01931.x. Review.

PMID:
19207976
16.

Summaries for patients. Antiviral therapy for chronic hepatitis B.

[No authors listed]

Ann Intern Med. 2007 Dec 4;147(11):I16. Epub 2007 Oct 1. No abstract available.

PMID:
17909200
17.

Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.

Reijnders JG, Deterding K, Petersen J, Zoulim F, Santantonio T, Buti M, van Bömmel F, Hansen BE, Wedemeyer H, Janssen HL; VIRGIL Surveillance Study Group.

J Hepatol. 2010 Apr;52(4):493-500. doi: 10.1016/j.jhep.2010.01.012. Epub 2010 Feb 4.

PMID:
20185191
18.

Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

Lee JM, Kim HJ, Park JY, Lee CK, Kim do Y, Kim JK, Lee HW, Paik YH, Lee KS, Han KH, Chon CY, Hong SP, Nguyen T, Ahn SH.

Antivir Ther. 2009;14(5):705-12.

PMID:
19704174
19.

[Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].

Benhamou Y.

Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S22-5. Review. French. No abstract available.

20.

[Treatment of chronic hepatitis B].

Asselah T, Castelnau C, Marcellin P.

Presse Med. 2006 Feb;35(2 Pt 2):327-34. Review. French.

PMID:
16493337
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk